Masroor, Darakhshan
Khaliq, Sheikh Abdul
Ahmad, Syed Muzzammil
Mazhar, Farah
Azhar, Iqbal
Article History
Received: 28 May 2022
Accepted: 6 August 2024
First Online: 5 September 2024
Declarations
:
: The Institutional Bio-Ethical Committee (IBC) of University of Karachi approved the study design and methods (Reference Number: IBC-KU 50). Study is also approved by Advanced Studies & Research Board, University of Karachi (Reference Number: ASRB/No./04164/Pharm.). Prior to initiating the survey, a written informed consent was obtained from each patient after explaining the research and its objectives. All researchers ensured the maintenance of patient data confidentiality in compliance with the Declaration of Helsinki [].
: Not applicable.
: The authors declare no competing interests.